The majority of reported cases of TRPA have associated cystic fibrosis, the δF508 CFTR (cystic fibrosis transmembrane conductance regulator) mutation being thought to be a predisposing factor for this disease [2]. This evidence concerns the gene TPSG1 and cystic fibrosis.